FW: HCV Advocate Email Alert

[Guest guest]

-------- Begin forwarded message --------Subject: HCV Advocate Email AlertDate: 2/20/11 6:02:38 PMFrom: " www.hcvadvocate.org " To: emailalert@... February 21, 2011 HCV & raquo; February Newsletter & raquo; HCV Fact Sheets & raquo; Educational Materials & raquo; HCSP Streaming Videos Greetings: This was another incredible week with news about hepatitis C. The most important news item was the press release from Tibotecannouncing the start of phase III studies of their once-a-day dose of TMC-435-an HCV protease inhibitor. Stay tuned for information about this drug - in addition to the once-a-day dosing the preliminary data from the phase II studies looks very promising. 2. In addition to the Tibotec news you might want to check out what others are reading about hepatitis B and hepatitis C. The Top Ten English and Spanish fact sheetsinclude Acetaminophen and Your Liver , Short Term Disability , and more. On the HBV Advocate the TopTen includes How to Interpret Hepatitis B Antibody and Viral Tests , Hepatitis B Antigen and Antibody Tests and many more. 3. Jacques Chambers monthly column is on " Taxation of Disability Benefits " - a must read if you are paying into disability and want to make sure you are reporting the income correctly. 4. Centerforcein cooperation with San Quentin and prison peer educators have produced three videos titled " Mythbusters, which you can find on our Patient Education page under streaming videos. " Feel free to pass these around to other prisons that are educating peers about hepatitis C. 5. Our HCSP Training Calendarhas been updated through April 2011. If you are interested in attending one of our trainings the flyers will soon be available for the confirmed dates and locations so that you can find out more information on how to register. 6. Lastly, the CDC in cooperation with AASLD is sponsoring a Hepatitis Single Topic Conference on June 4-5, 2011 in Atlanta, GA. The conference topic is " Chronic Viral Hepatitis Strategies to Improve Effectiveness of Screening and Treatment. " Don't forget to keep checking out our blogfor more about the most recent news stories. Sincerely, Alan Join us on Twitter -. Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate www.hcvadvocate.orgEditor-in-Chief, HBV Advocate www.hbvadvocate.org. **Questions and Comments: Questions and/or comments can be directed to alanfranciscus@...**To receive the eblast in your email inbox simply send an e-mail to: listserv@...with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case. . HBV & raquo; HBV Journal Review & raquo; HBV Factsheets & raquo; HBV & HCV Advocate Hepatitis Blog & raquo; Stay connected with all the late-breaking news on hepatitis B-Join us on Twitter

[Guest guest]

-------- Begin forwarded message --------Subject: HCV Advocate Email AlertDate: 3/1/11 11:53:54 AMFrom: " www.hcvadvocate.org " To: emailalert@... March 1, 2011 HCV & raquo; February Newsletter & raquo; HCV Fact Sheets & raquo; Educational Materials & raquo; HCSP Streaming Videos Hello: I am Kukka, HBV Project Manager with the Hepatitis C Support Project (HCSP). Every month, I scour dozens of medical journals to find out the latest about hepatitis B treatment and disease progression and prevention. The type of reports I look for can range from a study on a successful community approach to screening and immunizing immigrants against hepatitis B, to an analysis that identifies which patients would benefit most from pegylated interferon. 1. In this month's HBV Journal Review, posted at the HCSP HBV dedicated site, the HBV Advocate, readers can learn about how lives and health care dollars are saved when treatment begins early, how in vitro fertilization can transmit HBV, and how doctors lack clear guidelines about when it's safe for patients to stop antiviral treatment. 2. Also... be sure to check out the HCV AdvocateNewsletterfor the month of March, 2011. In This Issue: HCV Protease Inhibitor-TMC435: Phase 3 Studies Alan Franciscus, Editor-in-Chief Hepatitis C in Egypt Alan Franciscus, Editor-in-Chief HCV Snapshots Lucinda K. Porter, RN Liver Transplantation: An Overview Liz Highleyman HealthWise: The Power Is in Our Hands Lucinda K. Porter, RN Don't forget to keep checking out our blogfor more about the most recent news stories. Sincerely, Join us on Twitter -. Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate www.hcvadvocate.orgEditor-in-Chief, HBV Advocate www.hbvadvocate.org. **Questions and Comments: Questions and/or comments can be directed to alanfranciscus@...**To receive the eblast in your email inbox simply send an e-mail to: listserv@...with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case. . HBV & raquo; HBV Journal Review & raquo; HBV Factsheets & raquo; HBV & HCV Advocate Hepatitis Blog & raquo; Stay connected with all the late-breaking news on hepatitis B-Join us on Twitter

[Guest guest]

-------- Begin forwarded message --------Subject: HCV Advocate Email AlertDate: 3/16/11 8:18:06 PMFrom: " www.hcvadvocate.org " To: emailalert@... March 17, 2011 HCV & raquo; March Newsletter & raquo; HCV Fact Sheets & raquo; Educational Materials & raquo; HCSP Streaming Videos Hello: This week we launched a major initiative to help educate people about safer tattooing practices to prevent transmission of hepatitis B, hepatitis C, bacterial infections and other pathogens- Hepatitis & Tattoos . The heptitistattoos.orgwebsite will feature regular articles on tattooing and pictures, but the main message is that getting a tattoo is safe - as long as safety precautions are closely followed. Additional articles and postings include: • " Supervising Your PPO Health Insurance Claims , " by Jacques Chambers. In this month's columnJacques discusses the importance of becoming knowledgeable about PPO Health claims in order to make sure that you know what is and what is not covered. • National Institutes of Health (NIH) Department of Complementary and Alternative medicine (CAM) released a Special Report on HCV and CAM. The Website and the special report on hepatitis C and CAM contain a lot of useful information about herbs, guidelines on dietary supplements and nutraceuticals (food or food products that provides medical benefit) with direct links to their Website. • Check out the list of the Top Ten Articles our viewers viewed in February to see if there is anything you missed of importance - HCV, HBV. • Be sure to check out our updated Drug Pipeline: Hepatitis C Treatments in Current Clinical Development • Lastly, we continue to provide brief overviews on some of the most compelling News Stories with direct links to the actual articles on our Blogand Websites- HCV, HBV. One recent article noted that the Food and Drug Administration plans to review the Merck and Vertex HCV protease data in late April. So the approval process is underway and let's keep our fingers crossed that the new medications are approved as soon as possible so that people can have access to these new and potentially life-saving medications. Sincerely, Alan Join us on Twitter -. Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate www.hcvadvocate.orgEditor-in-Chief, HBV Advocate www.hbvadvocate.org. **Questions and Comments: If you have questions or comments please do not reply to this email . Questions and/or comments can be directed to alanfranciscus@...**Unsubscribe Information:

[Guest guest]

-------- Begin forwarded message --------Subject: HCV Advocate Email AlertDate: 4/3/11 3:38:06 PMFrom: " www.hcvadvocate.org " To: emailalert@... April 4, 2011 HCV & raquo; April Newsletter & raquo; HCV Fact Sheets & raquo; Educational Materials & raquo; HCSP Streaming Videos Greetings: This week's postings include: Top News from EASL 2011: Here are a few highlights: • Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment. • FDA Fast Track designations granted for both the protease inhibitor BI 201335 plus standard-of-care and the interferon-free combination of BI 201335 with polymerase inhibitor, BI 207127. • PegIFN-lambda shows superior virological response and improved safety than PegIFN-alpha-2a. • First Vaccine For Viral Hepatitis C Could Become A Reality. April 2011 HCV Advocate newsletter that includes: • Why We Should Test-Editorial: Testing everyone for HCV regardless of medical coverage is a very contentious issue, Now that we will have new response-guided treatment regimens and rapid testing, it may be time to take another look. • HCV Snapshots this month is a pot pourri of interesting items from Silibinin monotherapy to IL28B Genomic-based Treatment Paradigms. • Liver Transplantation: HCV Recurrence and Treatment, by Liz Highleyman, is a must read. • HEALTHWISE: Humor, Health, and Hepatitis C is yet another delightful essay, by Lucinda K. Porter, RN., on living with hepatitis C. April HBV Journal Review that includes: • Rate of HBV drops in the U.S. • Screening All Chemotherapy Patients for Hepatitis B. • Connections between Hepatitis B and Diabetes. • Biopsy and Treatment Recommended in HBeAg-negative Patients. • Immunization at Birth Reduces Infection, but Parents May Still Transmit Infection. • HIV-HBV Coinfected Face Higher Death Rates than HIV-HCV Coinfected. ...and more New Hepatitis & Tattos Blog:Be sure to check out and participate in our new blog. Don't forget to check out our HCV & HBV Advocate Hepatitis Blogfor more about the most recent news stories. Sincerely, Alan Join me on Twitter -. Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate www.hcvadvocate.orgEditor-in-Chief, HBV Advocate www.hbvadvocate.org. **Questions and Comments: If you have questions or comments please do not reply to this email . Questions and/or comments can be directed to alanfranciscus@...**Unsubscribe Information:

[Guest guest]

-------- Begin forwarded message --------Subject: HCV Advocate Email AlertDate: 9/20/11 12:00:39 PMFrom: " www.hcvadvocate.org " To: emailalert@... September 20, 2011 HCV & raquo; September Newsletter & raquo; HCV Fact Sheets & raquo; Educational Materials & raquo; HCSP Streaming Videos Hello: Just a short eblast with some mid-month updates. Hepatitis C Treatments in Current Clinical Development : Updated September 19. Click here Top 10 HCV Downloads of the Month (English & Spanish): Updated September 19. Click hereTop 10 HBV Downloads of the Month: Updated September 19. Click hereNew: Tattoo After Care Fact Sheet : To Download this Fact Sheet Click here HBV and HCV Blog : Read about the latest and greatest in the news • Danger Signal Limits Hepatitis C Infection • How our liver kills 'killer cells' • Shark-Derived Drug May Treat Viruses • Rapid anti-HCV tests can provide sensitive and specific anti-HCV results for high-risk patients • Inhibitex Commences Dosing of Phase 2 Clinical Trial of INX-189 in HCV Infected Genotype 2/3 Patients • Bristol-Myers's Once-Daily Hepatitis C Drug Works in Study • Sanford Guide Introduces New Hepatitis Guide • Coffee Helps Minimize Hepatitis C Treatment Side Effects • Early Data on BMS-790052 HCV NS5A Inhibitor Published • Hepatitis B and C Coinfection among HIV Positive People in the U.S. • NJ doctor loses license after hepatitis B outbreak Respectfully, Alan Join us on Twitter - Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate www.hcvadvocate.orgEditor-in-Chief, HBV Advocate www.hbvadvocate.org *Questions and Comments: If you have questions or comments please do not reply to this email . Questions and/or comments can be directed to alanfranciscus@...**Unsubscribe Information: